ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.
| Business Activity | PASS |
| Debt Ratio (0.18%) | PASS |
| Cash Ratio (0.05%) | PASS |
| Receivables Ratio (0.00%) | PASS |
| Revenue Ratio (0.00%) | PASS |
| Overall | PASS |
| Date | EPS Est. | Reported EPS | Surprise % |
|---|---|---|---|
| 2026-08-13 | — | Pending | -- |
| 2021-02-22 | -0.04 | 0.03 | +175.0% |
| 2020-11-12 | -0.08 | -0.04 | +50.0% |
| 2020-08-12 | -0.10 | -0.11 | -10.0% |
| Period | Revenue | Net Income | EBITDA | Gross Profit | Op. Income | EPS |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10.4M | $1.9M | $2.6M | $4.7M | $2.0M | 0.21 |
| 2025-12-31 | $7.6M | -$2.8M | -$2.0M | $2.9M | -$58.0K | -0.31 |
| 2025-09-30 | $5.5M | -$139.7K | $648.7K | $2.4M | $20.1K | -0.02 |
| 2025-06-30 | $6.4M | $501.9K | $1.3M | $2.8M | $569.6K | 0.06 |
| 2025-03-31 | $8.1M | $1.4M | $2.2M | $3.4M | $1.1M | 0.16 |
| 2024-12-31 | — | — | — | — | — | — |
| Date | Name | Role | Shares | Value |
|---|---|---|---|---|
| 2026-03-20 | BRIGHAM MICHAEL F | Director | 25,000 | $146.0K |
| 2025-12-04 | TE BOEKHORST PAUL FRANCIS OLIVIER | Chief Executive Officer | 9,738 | $49.6K |
| 2025-12-03 | TE BOEKHORST PAUL FRANCIS OLIVIER | Chief Executive Officer | 9,785 | $48.6K |
| 2025-11-25 | TOMSCHE DAVID SCOTT | Director | 3,266 | $15.6K |
| 2025-06-12 | GATHAGAN BRYAN K | Director | 1,000 | $6.3K |
| 2025-06-11 | BASSE GLORIA F | Director | 3,530 | $17.0K |
| Holder | Shares | Value | % Held |
|---|---|---|---|
| Vanguard Capital Management LLC | 260.3K | $2.6M | 0.0% |
| Morgan Stanley | 221.7K | $2.2M | 0.0% |
| Renaissance Technologies, LLC | 151.8K | $1.5M | 0.0% |
| Cresset Asset Management, LLC | 135.3K | $1.4M | 0.0% |
| Bleichroeder LP | 101.6K | $1.0M | 0.0% |
| Geode Capital Management, LLC | 65.8K | $665.5K | 0.0% |
| Dimensional Fund Advisors LP | 56.0K | $567.0K | 0.0% |
| Steadtrust LLC | 54.4K | $550.2K | 0.0% |
| Vanguard Fiduciary Trust Co | 42.7K | $431.8K | 0.0% |
| Mesirow Financial Investment Management, Inc. | 42.5K | $429.9K | 0.0% |
$97.5M
3.38
0.505
$27.6M
$12.8M
+31.3%
0.70
0.0%
73
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| STUB | 0.240 |
| MPLT | 0.238 |
| XZO | 0.207 |
| AEBI | 0.170 |
| FLOC | 0.168 |
| Ticker | Correlation |
|---|---|
| LGN | -0.165 |
| ITHMR.AE | -0.151 |
| NBK.KW | -0.148 |
| 4001.SR | -0.142 |
| LBRDP | -0.141 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.